Urinary transforming growth factor-β1 in membranous glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 12, Issue 12, 1997, Pages 2562-2568

  Honkanen, E ^a   Teppo, A M ^a   Tornroth T ^a   Groop, P H ^a   Gronhagen Riska C ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Fibrosis; Growth factors; Immunosuppressive therapy; Progression

Indexed keywords

ALBUMIN; CREATININE; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENT; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; REMISSION; URINARY EXCRETION;

EID: 0030724804     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.12.2562     Document Type: Article

References (35)

1. Donadio JV Jr, Torres VE, Velosa JA et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 1988; 33: 708-715
2. Honkanen E, Törnroth T, Grönhagen-Riska C. Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant 1992; 7 [Suppl. 1] 35-41
3. Scieppati A, Mosconi L, Perna A et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993; 329: 85-89
4. Grönhagen-Riska C, von Willebrand E, Tikkanen T et al. The effect of cyclosporin A on the interstitial mononuclear cell infiltration and the induction of Heymann's nephritis. Clin Exp Immunol 1990; 79: 266-272
5. Lee HS, Koh HI. Nature of progressive glomerulosclerosis in human membranous nephropathy. Clin Nephrol 1993; 39: 7-16
6. Wehrmann M, Bohle A, Bogenschutz O et al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1989; 31: 67-76
7. Abboud HE. Growth factors in glomerulonephritis. Kidney Int 1993; 43: 252-267
8. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1-7
9. Bruijn JA, Roos A, De Geus B, De Heer E. Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 1994; 123: 34-47
10. Callard RE, Gearing AJH. Cytokine Facts Book. Academic Press, London, 1994; 235-240
11. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β. Nature 1990; 346: 371-374
12. Okuda S, Languino LR, Ruoslahti E, Border WA. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990; 86: 453-462
13. Ponticelli C, Zucchelli P, Passerini P et al. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1989; 320: 8-13
14. Cattran DC, Greenwood C, Ritchie S et al., for the Canadian Glomerulonephritis Study Group. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 1995; 47: 1130-1135
15. Pei Y, Cattran D, Greenwood C. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 1992; 42: 960-966
16. Honkanen E, Törnroth T, Grönhagen-Riska C, Sankila R. Long-term survival in idiopathic membranous glomerulonephritis: can the course be clinically predicted? Clin Nephrol 1994; 41: 127-134
17. Horii Y, Muraguchi A. Iwano M et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 1989; 143: 3949-3955
18. Dohi K, Iwano M, Muraguchi A et al. The prognostic significance of urinary interleukin-6 in IgA nephropathy. Clin Nephrol 1991; 35: 1-5
19. Gesualdo L, Ranieri E, Di Paolo S et al. Is urinary EGF/IL-6 ratio a prognostic marker for the progression of renal damage? (Abstr) Nephrol Dial Transplant 1995; 10: 926
20. Schulze M, Donadio JV Jr, Pruchno CJ et al. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int 1991; 40: 533-538
21. Brenchley PE, Coupes B, Short CD, O'Donoghue DJ, Ballardie FW, Mallick NP. Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int 1992; 41: 933-937
22. Honkanen E, Teppo A-M, Meri S, Lehto T, Grönhagen-Riska C. Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 1994; 9: 1553-1559
23. Honkanen E, Törnroth T, Pettersson E, Kuhlbäck B. Glomerulonephritis in renal allografts: results of 18 years of transplantations. Clin Nephrol 1984; 21: 210-219
24. Churg J, Bernstein J, Glassock RJ. Renal disease. Classification and Atlas of Glomerular Diseases, 2nd edn. Ikagu-Shoin, Tokyo,1995
25. Rosen S, Törnroth T, Bernard DB. Membranous glomerulonephritis. In: Tisher CC, Brenner BM, ed. Renal Pathology with Clinical and Functional Correlations. JB Lippincott, Philadelphia, 1989; 196-227
26. Noh JW, Wiggins R, Phan SH. Urine transforming growth factor-β activity is related to the degree of scarring in crescentic nephritis in the rabbit. Nephron 1993; 63: 73-78
27. Kanai H, Mitsuhashi H, Ono K, Yano S, Naruse T. Increased excretion of urinary transforming growth factor beta in patients with focal glomerulosclerosis. Nephron 1994; 66:391-395
28. Coupes BM, Newstead CG, Short CD, Brenchley PEC. Transforming growth factor β1 in renal allograft recipients. Transplantation 1994; 57: 1727-1731
29. Yoshioka K, Takemura T, Murakami K et al. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993; 68: 154-163
30. Burton C, Harris KPG. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996; 27: 765-775
31. Border WA, Okuda S, Languino LR, Ruoslahti E. Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 1990; 37: 689-695
32. Nakamura T, Miller D, Ruoslahti E, Border WA. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β. Kidney Int 1992; 41: 1213-1221
33. Yamamoto T, Noble NA, Miller DA, Border WA. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916-927
34. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, Fujishima M. TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 1994; 45: 525-536
35. Wahl SM, McCartney-Francis N, Allen JB, Dougherty EB, Dougherty SF. Macrophage production of TGF-β and regulation by TGF-β. Ann NY Acad Sci 1990; 593: 188-196